NZ244458A - Metal alkoxides of taxane derivatives - Google Patents

Metal alkoxides of taxane derivatives

Info

Publication number
NZ244458A
NZ244458A NZ244458A NZ24445892A NZ244458A NZ 244458 A NZ244458 A NZ 244458A NZ 244458 A NZ244458 A NZ 244458A NZ 24445892 A NZ24445892 A NZ 24445892A NZ 244458 A NZ244458 A NZ 244458A
Authority
NZ
New Zealand
Prior art keywords
solution
taxol
mixture
ethyl acetate
thf
Prior art date
Application number
NZ244458A
Inventor
Robert A Holton
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State filed Critical Univ Florida State
Publication of NZ244458A publication Critical patent/NZ244458A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

A metal alkoxide having the following formula: <IMAGE> (1) wherein T1 is hydrogen or a hydroxy protecting group, Z is -OT2, or -OCOCH3, T2 is hydrogen or a hydroxy protecting group, and M is selected from the group comprising Group IA, IIA and transition metals are useful in the preparation of biologically active derivatives of baccatin III and 10-deacetyl baccatin III.

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number £44458 <br><br> 2 4 4 4 5 8 <br><br> Priority Date(s): .2,3*33^,.?;f+\^.. <br><br> It <br><br> No.: Date: <br><br> Complete L'.on Filsd: <br><br> Class: .conoid j* <br><br> Publication Date: <br><br> P.O. Journal, No: ....... /3W., <br><br> NEW ZEALAND <br><br> PATENTS ACT, 1953 <br><br> COMPLETE SPECIFICATION <br><br> METAL ALKOXIDES <br><br> We, FLORIDA STATE UNIVERSITY, a corporation of the State of Florida, United States of America, of 2035 East Paul Dirac Drive, Tallahassee, Florida 32310, United States of America hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:- <br><br> - 1 - <br><br> (followed by page la) <br><br> 244 458 <br><br> - la - <br><br> BACKGROUND OF THE INVENTION <br><br> The present invention is directed to novel metal alkoxides useful in the preparation of derivatives of baccatin III and 10-deacetyl baccatin III such as taxol, 10 taxotere and other taxane derivatives which have biological activity. <br><br> The taxane family of terpenes, of which taxol is a member, has attracted considerable interest in both the biological and chemical arts. Taxol is a promising cancer 15 cheraotherapeutic agent with a broad spectrum of antileukemic and tumor-inhibiting activity. Taxol has the following structure: <br><br> OAc <br><br> CfiHgCONH O . „ .. <br><br> i u ;' 0H <br><br> /V*J' v s / \ --**■ n C6H^ 1 ommifls <br><br> CI) <br><br> OH <br><br> \ / "&lt;11116/* 7 \ <br><br> OH i H ^r\ <br><br> s OAc\ --0 OCOCgHg 30 <br><br> Because of this promising activity, taxol is currently 20 undergoing clinical trials in both France and the United States. <br><br> The supply of taxol for these clinical trials is presently being provided by the bark from Taxus brevifolia <br><br> 12 APR 1994 <br><br> 2 4 4 4 5 <br><br> (Western Yew). However, taxol is found only in minute quantities in the bark of these slow growing evergreens, causing considerable concern that the limited supply of taxol will not meet the demand. Consequently, chemists in 5 recent years have expended their energies in trying to find a viable synthetic route for the preparation of taxols. So Ear, the results have not been entirely satisfactory. <br><br> One synthetic route that has been proposed is directed to the synthesis of the tetracyclic taxane nucleus 10 from commodity chemicals. A synthesis of the taxol congener taxusin has been reported by Holton, et al. in JACS 110. 6558 (1988). Despite the progress made in this approach, the final total synthesis of taxol is, nevertheless, likely to be a multi-step, tedious, and 15 costly process. <br><br> An alternate approach to the preparation of taxol has been described by Greene, et al. in JACS 110, 5917 ( 1988), and involves the use of a congener of taxol, 10-deacetyl baccatin III which has the structure of formula 20 II shown below: <br><br> HOtlMHI <br><br> Cii) <br><br> 10-deacetyl baccatin III is more readily available than taxol since it can be obtained from the needles of Taxus baccata. According to the method of Greene et al., 25 10-deacetyl baccatin III is converted to taxol by <br><br> # <br><br> 3 <br><br> attachment of the C-10 acetyl group and by attachment of the C-13 B-amido ester side chain through the esterification of the C-13 alcohol with a B-amido carboxylic acid unit. Although this approach requires 5 relatively few steps, the synthesis of the B-amido carboxylic acid unit is a multi-step process which proceeds in low yield, and the coupling reaction is tedious and also proceeds in low yield. However, this coupling reaction is a key step which is required in every contemplated 10 synthesis of taxol or biologically active derivative of taxol, since it has been shown by Wani, et al. in JACS 93. 2325 (1971) that the presence of the B-amido ester side chain at C13 is required for anti-tumor activity. <br><br> More recently, it has been reported in Colin et 15 al. U.S. Patent No. 4,814,470 that taxol derivatives of the formula III below, have an activity significantly greater than that of taxol (I). <br><br> R' represents hydrogen or acetyl and one of R*' and R''' 20 represents hydroxy and the other represents tert-butoxy-carbonylamino and their stereoisomeric forms, and mixtures thereof. <br><br> According to Colin et al., U.S. Patent 4,418,470, the products of general formula (III) are obtained by the <br><br> 2 4 4 4 5 <br><br> 4 <br><br> action of the sodium salt of tert-butyl N-chlorocarbamate on a product of general formula: <br><br> J^l O Q OCOOCH2CI3 <br><br> co-o <br><br> J <br><br> C0Hs in which R' denotes an acetyl or 2,2,2-trichloroethoxy-5 carbonyl radical, followed by the replacement of the <br><br> 2,2,2-trichloroethoxycarbonyl group or groups by hydrogen. It is reported by Denis et al. in U.S. Patent No. 4,924,011, however, that this process leads to a mixture of isomers which has to be separated and, as a result, not all 10 the baccatin III or 10-deactylbaccatin III employed for the preparation of the product of general formula (IV) can be converted to a product of general formula (III). <br><br> In an effort to improve upon the Colin et al. process, Denis et al. disclose a different process for 15 preparing derivatives of baccatin III or of 10-deactylbaccatin III of general formula <br><br> Civ) <br><br> OH ; H OCOCgHg <br><br> OCOCH- <br><br> 9 / / £ £ <br><br> L \ 3 <br><br> in which R' denotes hydrogen or acetyl wherein an acid of general formula: <br><br> o—R, <br><br> C vi) <br><br> Cch3)3coconhv/ cooh <br><br> in which R-^ is a hydroxy-protecting group, is condensed with a taxane derivative of general formula: <br><br> ho -- <br><br> OCOCH, <br><br> OCOCgHg <br><br> (VII) <br><br> in which R2 is an acetyl hydroxy-protecting group and R3 is a hydroxy-protecting group, and the protecting groups R^, R3 and, where appropriate, R2 are then replaced by 10 hydrogen. However, this method employs relatively harsh conditions, proceeds with poor conversion, and provides less than optimal yields. <br><br> A major difficulty remaining in the synthesis of taxol and other potential anti-tumor agents is the lack of 15 baccatin III and 10-deacetyl baccatin III derivatives which have been activated at the C-13 oxygen. Development of such derivatives would permit attachment of the B-amido ester side chain in high yield and thus, facilitate the synthesis of taxol as well as related anti-tumor agents 20 having a modified set of nuclear substituents or a modified C-13 side chain. <br><br> •&gt;' /' ■ -ft <br><br> ■ "7 ; 'T <br><br> 6 <br><br> Another major difficulty encountered in the synthesis of taxol is that known processes for the attachment of the B-amido ester side chain at C-13 are generally not sufficiently diastereoselective. Therefore 5 the side chain precursor must be prepared in optically active form to obtain the desired diastereomer during attachment. <br><br> SUMMARY OF THE INVENTION <br><br> Among the objects of the present invention, 10 therefore, is the provision of activated baccatin III and 10-deacetyl baccatin III derivatives which permit attachment of the B-amido ester side chain in high yield, the provision of such derivatives which permit the use of a racemic mixture of side chain precursor, eliminating the 15 need for the expensive, time-consuming process of separating the precursor into its respective isomeric forms, and the provision of such derivatives which permit the preparation of taxanes having greater variety in the side-chain. <br><br> 20 Briefly, therefore, the present invention is directed to a metal alkoxide having the formula: <br><br> MOimiiii ot, <br><br> (1) <br><br> wherein T^ is hydrogen or a hydroxy protecting group, Z is -OT2, or -OCOCH3, T2 is hydrogen or a hydroxy <br><br> 25 protecting group, and M is a metal, preferably, Li, Mg, Na, K or Ti. <br><br> 2 4 4 4 5 8 <br><br> 7 <br><br> Other objects and features of this invention will be in part apparent and in part pointed out hereinafter. <br><br> DETAILED DESCRIPTION <br><br> Metal alkoxides (1) are activated derivatives of 5 baccatin III and/or 10-deacetyl baccatin III and have particular utility in a process for the preparation of taxol, taxotere and other biologically active taxane derivatives. In accordance with the present invention, metal alkoxides (1) are reacted with G-lactam (2) to form a 10 G-amido ester intermediate. The intermediate is then converted to a biologically active taxane derivative. B-lactam (2) has the general formula: <br><br> * <br><br> '— <br><br> 1 2 4 3 <br><br> j <br><br> C2) <br><br> ^3 *2 <br><br> wherein <br><br> 15 Ri is -ORg, -SR7, or -NRgRg,* <br><br> R2 is hydrogen, alkyl, alkenyl, alkynyl, aryl, or heteroaryl; <br><br> R3 and R4 are independently hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or acyl, provided, 20 however, that R3 and R4 are not both acyl; <br><br> R5 is —COR^g, -COOR^o, —COSR^g, —CONRgR-^g, <br><br> -SO2R11t ~P0Ri2Ri3; <br><br> R6 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, or hydroxy protecting group; <br><br> 25 R7 is alkyl, alkenyl, alkynyl, aryl, heteroaryl, <br><br> or sulfhydryl protecting group; <br><br> 8 <br><br> Rg is hydrogen, alkyl, alkenyl, alkynyl, aryl, or heteroaryl; <br><br> Rg is an amino protecting group; <br><br> R10 is alkyl, alkenyl, alkynyl, aryl, or 5 heteroaryl; <br><br> R^2. alkyl, alkenyl, alkynyl, aryl, heteroaryl, -ORiq/ or —NRgR^^; <br><br> R22 an&lt;3 Ri3 are independently alkyl, alkenyl, alkynyl, aryl, heteroaryl, -OR10, or -NRgR14; and 10 R14 is hydrogen, alkyl, alkenyl, alkynyl, aryl, <br><br> or heteroaryl. <br><br> In accordance with the present invention, R5 of 13-lactam (2) is preferably -COR^q with Rjq with R^q being aryl, p-substituted phenyl, or lower alkoxy, and most 15 preferably, phenyl, methoxy, ethoxy, tert-butoxy ("tBuO"; (CH3)3CO-) or wherein X is CI, Br, F, CH30-, or N02-. Preferably R2 and R4 are hydrogen or lower alkyl. R3 is preferably aryl, 20 most preferably, naphthyl, phenyl, <br><br> f .? <br><br> 9 <br><br> 'OMe <br><br> Ph or wherein X is as previously defined, Me is methyl and Ph is phenyl. Preferably, is selected from -ORg, -SRy or 5 -NRgRg wherein Rg, R? and Rg, are hydroxy, sulfhydryl, and amine protecting groups, respectively, and Rg is hydrogen, alkyl, alkenyl, alkynyl, aryl, or heteroaryl. Most preferably, R^ is -ORg wherein Rg is triethylsilyl ("TES"), 1-ethoxyethyl ("EE") or 2,2,2-trichloroethoxymethyl. 10 The 13-lactam alkyl groups, either alone or with the various substituents defined hereinabove are preferably lower alkyl containing from one to six carbon atoms in the principal chain and up to 15 carbon atoms. They may be straight or branched chain and include methyl, ethyl, 15 propyl, isopropyl, butyl, isobutyl, tert-butyl, aryl, hexyl, and the like. <br><br> the various substituents defined hereinabove are preferably lower alkenyl containing from two to six carbon atoms in 20 the principal chain and up to 15 carbon atoms. They may be straight or branched chain and include ethenyl, propenyl, isopropenyl, butenyl, isobutenyl, aryl, hexenyl, and the like. <br><br> 25 the various substituents defined hereinabove are preferably lower alkynyl containing from two to six carbon atoms in the principal chain and up to 15 carbon atoms. They may be <br><br> The 13-lactam alkenyl groups, either alone or with <br><br> The 13-lactam alkynyl groups, either alone or with <br><br> ^ f / / vT O <br><br> / Li, I', is. " ; rl <br><br> 10 <br><br> straight or branched chain and include ethynyl, propynyl, butynyl, isobutynyl, aryl, hexynyl, and the like. <br><br> The 13-lactam aryl moieties described, either alone or with various substituents, contain from 6 to 15 5 carbon atoms and include phenyl, a-naphthyl or fi-naphthyl, etc. Substituents include alkanoxy, protected hydroxy, halogen, alkyl, aryl, alkenyl, acyl, acyloxy, nitro, amino, amido, etc. Phenyl is the more preferred aryl. <br><br> As noted above, R^ of 13-lactam (2) may be -ORg 10 with Rg being alkyl, acyl, ethoxyethyl ("EE"), <br><br> triethylsilyl ("TES"), 2,2,2-trichloroethoxymethy1, or other hydroxyl protecting group such as acetals and ethers, i.e., methoxymethyl ("MOM"), benzyloxymethyl; esters, such as acetates; carbonates, such as methyl carbonates; and 15 alkyl and aryl silyl such as triethylsilyl, trimethylsilyl, dimethyl-t-butylsilyl, dimethylarylsilyl, dimethyl-heteroarylsilyl, and triisopropylsilyl, and the like. A variety of protecting groups for the hydroxyl group and the synthesis thereof may be found in "Protective Groups in 20 Organic Synthesis" by T. W. Greene, John Wiley and Sons, 1981. The hydroxyl protecting group selected should be easily removed under conditions that are sufficiently mild, e.g., in 48% HF, acetonitrile, pyridine, or 0.5% HCl/water/ethanol, and/or zinc, acetic acid so as not to 25 disturb the ester linkage or other substituents of the taxol intermediate. <br><br> Also as noted previously, Ry may be a sulfhydryl protecting group and Rg may be an amine protecting group. Sulfhydryl protecting groups include hemithioacetals such 30 as 1-ethoxyethyl and methoxymethyl, thioesters, or thiocarbonates. Amine protecting groups include carbamates, for example, 2,2,2-trichloroethylcarbamate or tertbutylcarbamate. A variety of sulfhydryl and amine protecting groups may be found in the above-identified text 35 by T. W. Greene. <br><br> m 4 H o <br><br> 11 <br><br> The 13-lactams (2) can be prepared from readily available materials, as is illustrated in schemes A and B below: <br><br> Scheme A <br><br> ci <br><br> Ar OEE <br><br> ch3o, <br><br> OCH, <br><br> Vf° <br><br> Ar OEE <br><br> cd <br><br> Ar OAc b <br><br> HW° <br><br> ^ \ <br><br> Ar OAc <br><br> Scheme B <br><br> A <br><br> TESO OEt <br><br> ArC HO <br><br> H. <br><br> rf <br><br> ^—\ Ar 'OTES <br><br> Ar OTES <br><br> reagents: (a) triethylamine, CH2C12, 25°C, 18h; (b) 4 equiv eerie ammonium nitrate, CH3CN, -10°C, 10 min; (c) KOH, THF, H20, 0°C, 30 min; (d) ethyl vinyl ether, THF, toluene sulfonic acid (cat.), 0°C, 1.5h; (e) n-butyllithium, ether, 15 -78°C, 10 min; benzoyl chloride, -78°C, lh; (f) lithium <br><br> 4 <br><br> 12 <br><br> diisopropyl amide, THF -78°C to -50°C; (g) lithium hexamethyldisilazide, THF -78°C to 0°C; (h) THF, -78°C to 25 °C, 12h. <br><br> The starting materials are readily available. In 5 scheme A, a-Acyloxy acetyl chloride is prepared from glycolic acid, and, in the presence of a tertiary amine, it cyclocondenses with imines prepared from aldehydes and p-methoxyaniline to give l-p-methoxyphenyl-3-acyloxy-4-arylazetidin-2-ones. The p-methoxyphenyl group can be 10 readily removed through oxidation with eerie ammonium nitrate, and the acyloxy group can be hydrolyzed under standard conditions familiar to those experienced in the art to provide 3-hydroxy-4-arylazetidin-2-ones. The 3-hydroxyl group is protected with 1-ethoxyethyl, but may 15 be protected with variety of standard protecting groups such as the triethylsilyl group or other trialkyl (or aryl) silyl groups. In Scheme B, ethyl-a-triethylsilyloxyacetate is readily prepared from glycolic acid. <br><br> The racemic fl-lactams may be resolved into the 20 pure enantiomers prior to protection by recrystallization of the corresponding 2-methoxy-2-(trifluoromethyl) phenylacetic esters. However, the reaction described hereinbelow in which the fi-amido ester side chain is attached has the advantage of being highly diastereo-25 selective, thus permitting the use of a racemic mixture of side chain precursor. <br><br> The 3-(l-ethoxyethoxy)-4-phenylazetidin~2-one of Scheme A and the 3-(l-triethylsilyl)-4-phenylazetidin-2-one of Scheme B can be converted to B-lactam (2), by treatment 30 with a base, preferably n-butyllithium, and an acyl chloride, sulfonyl chloride, phosphinyl chloride, phosphoryl chloride or an alkyl chloroformate at -78°C or less. <br><br> Preferably, the metal alkoxides are prepared by 35 reacting an alcohol having two to four rings of the taxane <br><br> 2 4 4 4 <br><br> 13 <br><br> nucleus and a C-13 hydroxyl group with an organometallic compound in a suitable solvent. Most preferably, the alcohol is a protected baccatin III, in particular, 7-0-triethylsilyl baccatin III (which can be obtained as 5 described by Greene, et al. in JACS 110. 5917 (1988) or by other routes) or 7,lO-bis-O-triethylsilyl baccatin III. <br><br> As reported in Greene et al., 10-deacetyl baccatin III is converted to 7-O-triethylsilyl-lO-deacetyl baccatin III according to the following reaction scheme: <br><br> OCOCgHg <br><br> (3) (4a) <br><br> Under what is reported to be carefully optimized conditions, 10-deacetyl baccatin III is reacted with 20 equivalents of (C2H5)3SiCl at 23°C under an argon 15 atmosphere for 20 hours in the presence of 50 ml of pyridine/mmol of 10-deacetyl baccatin III to provide 7-triethylsilyl-10-deacetyl baccatin III (4a) as a reaction product in 84-86% yield after purification. <br><br> The reaction product (4a) is then acetylated with 20 5 equivalents of CH3COCI and 25 mL of pyridine/mmol of 4a at 0 °C under an argon atmosphere for 48 hours to provide 86% yield of 7-O-triethylsilyl baccatin III (4b) as reported by Greene, et al. in JACS 110. 5917 at 5918 (1988). <br><br> Alternatively, 7-triethylsilyl-10-deacetyl 25 baccatin III (4a) can be protected at C-10 oxygen with an <br><br> 24 4 4 5 <br><br> 14 <br><br> acid labile hydroxyl protecting group. For example, treatment of (4a) with n-butyllithium in THF followed by triethylsilyl chloride (1.1 mol equiv.) at 0°C gives 7,10-bis-0-triethylsilyl baccatin III (4c) in 95% yield. Also, (4a) can be converted to 7-0-treithylsilyl-10-(l-ethoxyethyl) baccatin III (4d) in 90% yield by treatment with excess ethyl vinyl ether and a catalytic amount of methane sulfonic acid. These preparations are illustrated in the reaction scheme below. <br><br> ococh3 <br><br> OSiCC2H3)3 <br><br> C4b) <br><br> CjHJN <br><br> OCOCH3 <br><br> ococghg <br><br> OSi(Cj Hg)3 <br><br> n-BuLi <br><br> OSlCC2Hg)3 <br><br> 4a <br><br> HOHMiti <br><br> (C2H5)3SiCl <br><br> (4c) <br><br> OCOCH3 <br><br> OCOCgHg <br><br> OEE <br><br> 0SiCC2H5)3 <br><br> CCAT)CH3S03H <br><br> HO'iinn <br><br> (4d) <br><br> OCOCHg <br><br> OCOCgHg <br><br> 2 4 4 4 5 <br><br> 15 <br><br> The 7-0-triethylsilyl baccatin III derivatives (4b, 4c or 4d) are reacted with an organometallic compound such as n-butyllithium in a solvent such as tetrahydrofuran (THF), to form the metal alkoxide 13-0-lithium-7-0-tri-5 ethylsilyl baccatin III derivative (5b, 5c or 5d) as shown in the following reaction scheme: <br><br> z <br><br> THF <br><br> CH- <br><br> CHaCHjCHjCHa + Lio-yj <br><br> CH3 OSiCC2H5)3 <br><br> OCOCqHJ <br><br> (22b) Z = C22c) Z = C22d) Z = <br><br> -OCOCH3 <br><br> -OSiCCjHsDg <br><br> -OEE <br><br> 10 As shown in the following reaction scheme, the <br><br> 13-0-lithium-7-0-triethylsilyl baccatin III derivative (5b, 5c, or 5d) reacts with 13-lactam (2) to provide an intermediate (6b, 6c, or 6d) in which the C-7 and C-2' hydroxyl groups are protected with a triethylsilyl group. <br><br> 15 The triethylsilyl and ethoxyethyl groups are then hydrolyzed under mild conditions so as not to disturb the ester linkage or the taxane substituents. <br><br> 16 <br><br> 2 4 4 4 <br><br> z z <br><br> ot. <br><br> 5 b-d <br><br> (2) <br><br> 6 b-d b, Z = -OCOCH3 c/ Z = -OSi(C2Hj)j d, Z = -OEE <br><br> 5 <br><br> wherein is a hydroxy protecting group; M is a metal; Ph is phenyl; Ac is acetyl; and to R5 are as previously defined. <br><br> 10 Group IA, IIA, IIIA, lanthanide or actinide element or a transition, Group IIIA, IVA, VA or VIA metal. Preferably, it is a Group IA, IIA or transition metal, and most preferably, it is lithium, magnesium, sodium, potassium or titanium. <br><br> 15 Both the conversion of the alcohol to the metal alkoxide and the ultimate synthesis of the taxane derivative can take place in the same reaction vessel. Preferably, the B-lactam is added to the reaction vessel after formation therein of the metal alkoxide. <br><br> 20 The organometallic compound n-butyllithium is preferably used to convert baccatin III or 10-deacetyl baccatin III to the corresponding metal alkoxide, but other sources of metallic substituent such as lithium diisopropyl amide, other lithium or magnesium amides, ethylmagnesium <br><br> Metal substituent, M, of metal alkoxide (3) is a <br><br> 17 <br><br> bromide, methylmagnesium bromide, other organolithium compounds, other organomagnesium compounds, organosodium, organot itanium or organopotassium may also be used. Organometallic compounds are readily available, or may be 5 prepared by available methods including reduction of organic halides with metal. For example, butyl bromide can be reacted with lithium metal in diethyl ether to give a solution of n-butyllithium in the following manner: <br><br> -10°C <br><br> CH3CH2CH2CH2Br + 2 Li *&gt; CH3CH2CH2CH2Li + LiBr <br><br> ECjO <br><br> 10 Although THF is the preferred solvent for the reaction mixture, other ethereal solvents, such as dimethoxyethane, or aromatic solvents may also be suitable. Certain solvents, including some halogenated solvents and some straight-chain hydrocarbons in which the 15 reactants are too poorly soluble, are not suitable. Other solvents are not appropriate for other reasons. For example, esters are not appropriate for use with certain organometallic compounds such as n-butyllithium due to incompatibility therewith. <br><br> 20 Although the reaction scheme disclosed herein is ideally directed to the synthesis of taxol, taxotere, and other taxane derivatives exemplified herein, it can be used with modifications in either the 13-lactam or the tetracyclic metal alkoxide to produce other compounds. 25 Thus, the 13-lactam ana the tetracyclic metal alkoxide can be derived from natural or unnatural sources, to prepare other synthetic taxols, taxol derivatives, 10-deacetyl-taxols, and the enantiomers and diastereomers thereof contemplated within the present invention. 30 The process of the invention also has the important advantage of being highly diastereoselective. Therefore racemic mixtures of the side chain precursors may <br><br> 24 4 4! <br><br> 18 <br><br> be used. Substantial cost savings may be realized because there is no need to resolve racemic G-lactams into their pure enantiomers. Additional cost savings may be realized because less side chain precursor, e.g., 60-70% less, is 5 required relative to prior processes. <br><br> The following examples illustrate the invention. <br><br> EXAMPLE 1 <br><br> Preparation of 2•-ethoxyethyl-7-triethylsilyl taxol, and subsequently taxol, from racemic 13-lactam: <br><br> 10 To a solution of 7-triethylsilyl baccatin III <br><br> (20mg, 0.028 mmol) in 1 ml of THF at -78°C was added dropwise 0.17 ml of a 0.164M solution of nBuLi in hexane. After 30 min at -78°C, a solution of cis-l-benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one (47.5 mg, 0.14 15 mmol) in 1 ml of THF was added dropwise to the mixture. The solution was allowed to slowly warm (over 1.5 h) to 0°C and was then stirred at 0°C for 1 h and 1 ml of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 20 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by flash chromatography to give 23 mg (80%) of (2*R, 3'S)-2'-ethoxyethyl-7-triethylsilyl taxol and 3.5 mg (13%) of 2',3'-epi(2'S, 3'R)-2'-ethoxyethy1-7-triethylsilyl taxol. 25 A 5 mg sample of (2'R, 3'S)-2'-ethoxyethyl- <br><br> 7-triethylsilyl taxol was dissolved in 2 ml of ethanol, and 0.5 ml of 0.5% aqueous HC1 solution was added. The mixture was stirred at 0°C for 30 h and diluted with 50 ml of ethyl acetate. The solution was extracted with 20 ml of 30 saturated aqueous sodium bicarbonate solution, dried over sodium sulfate and concentrated. The residue was purified by flash chromatography to provide 4.5 mg (ca.90%) taxol, <br><br> 2 4 4 4 <br><br> 19 <br><br> which was identical with an authentic sample in all respects. <br><br> A 5 mg sample of 2',3'-epi(2'S,3'R)-2'-ethoxy-ethyl-7-triethylsilyl taxol was dissolved in 2 ml of 5 ethanol and 0.5 ml of 0.5% aqueous HC1 solution was added. The mixture was stirred at 0°C for 30 h and diluted with 50 ml of ethyl acetate. The solution was extracted with 20 ml of saturated aqueous sodium bicarbonate solution, dried over sodium sulfate and concentrated. The residue was 10 purified by flash chromatography to provide 4.5 mg (ca.90%) of 2',3'-epitaxol. <br><br> EXAMPLE 2 <br><br> Preparation of 27-(bis)triethylsilyl taxol, and subsequently taxol, from racemic 13-lactam: <br><br> 15 To a solution of 7-triethylsilyl baccatin III <br><br> (lOOmg, 0.143 mmol) in 1 ml of THF at -45°C was added dropwise 0.087 ml of a 1.63M solution of nBuLi in hexane. After 1 h at -45°C, a solution of cis-l-benzoyl-3-triethylsilyloxy)-4-phenylazetidin-2-one (274 mg, 0.715 20 mmol) in 1 ml of THF was added dropwise to the mixture. <br><br> The solution was allowed to warm to 0°C and held at 0°C for . 1 h. One ml of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the 25 organic layer gave a residue which was purified by flash chromatography followed by recrystallization to give 131 mg (85%) of (2'R, 3'S)-2',7-(bis)triethylsilyl taxol and 15 mg (10%) of 2',3'-epi(2'S,3'R)-2',7-(bis)triethylsilyl taxol. <br><br> To a solution of 121.3 mg (0.112 mmol) of (2'R, 30 3'S)-2',7-(bis)triethylsilyl taxol in 6 ml of acetonitrile and 0.3 ml of pyridine at 0°C was added 0.9 ml of 48% aqueous HF. The mixture was stirred at 0°C for 8 h, then at 25°C for 6 h. The mixture was partitioned between <br><br> 24 4 4 <br><br> 20 <br><br> saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 113 mg of material which was purified by flash chromatography and recrystallization to give 94 mg (98%) taxol, which was 5 identical with an authentic sample in all respects. <br><br> To a solution of 5 mg of (2'R, 3 'S)-2' , 7-(bis) triethylsilyl taxol in 0.5 ml of acetonitrile and 0.03 ml of pyridine at 0°C was added 0.09 ml of 48% aqueous HF. The mixture was stirred at 0°C for 8 h, then at 25°C for 6 10 h. The mixture was partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 5 mg of material which was purified by flash chromatography and recrystallization to give 4.6 mg (ca. 95%) of 2',3'-epitaxol. <br><br> 24 4 4 5 <br><br> 21 <br><br> EXAMPLE 3 <br><br> Preparation of taxotere. <br><br> To a solution of 7,10-bis-triethylsilyl baccatin III (200 mg, 0.248 mmol)) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 5C, a solution of cis-1-(tert-butoxycarbonyl)-3-triethylsilyloxy-4-phenylazetidin-2-one (467 mg, 1.24 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 280 mg of crude 21,7,10-tris-triethylsilyl taxotere. <br><br> « <br><br> To a solution of 280 mg of the crude product obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 215 mg of material which was purified by flash chromatography to give 190 mg (95%) of taxotere, which was recrystallized from methanol/water. All analytical and spectral data were identical with that reported for taxotere in U. S. Patent 4,814,470. <br><br> EXAMPLE 4 <br><br> OAc o <br><br> 24 4458 <br><br> 22 <br><br> wherein Np2 is <br><br> Preparation of 3 '-desphenyl-3'-(2-naphthyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-triethylsilyloxy-4-(2-naphthyl)azetidin-2-one (620 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of, a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-3'-desphenyl-3'-(2-naphthyl) taxol and a small amount of the (2'S/3'R) isomer. <br><br> To a solution of 320 mg (0.283 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatogr'|^hKv^.oN give <br><br> ' * o\\ <br><br> 24 4 4 5 8 <br><br> 23 <br><br> 166 mg (64%) of 3'-desphenyl-3'-(2-naphthyl) taxol, which was recrystallized from methanol/water. <br><br> m.p. 164-165 °C;[a]25Na-52.6° (c 0.005, CHC13). <br><br> 1H NMR (CDCI3, 300 MHz) S 8.14 (d, J = 7.3 Hz, 2H; benzoate ortho) , 7.96 (m, 1H, aromatic), 7.90 (m, 1H, aromatic), 7.85 (m, 2H, aromatic), 7.76 (m, 2H, aromatic), 7.60 (m, 3H, aromatic), 7.52 (m, 4H, aromatic), 7.41 (m, 2H, aromatic), 7.01 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.26 (dd, J = 9.2, 9.2 Hz, 1H, H13), 5.97 (dd, J = 8.8, 2.5 Hz, 1H, H3' ) , 5.68 (d, J = 7.1 Hz, 1H, H2I3) , 4.93 (m, 1H, H5), 4.92 (m, 1H, H2'), 4.39 (m, 1H, H7), 4.30 (d, J = 8.5 Hz, 1H, H20a) , 4.20 (d, J = 8.5 Hz, 1H, H2013) , 3.81 (d, J = 7.1 Hz, 1H, H3), 3.60 (d, J - 5 Hz, 1H, 2'OH), 2.48 (m, 1H, H6a) , 2.45 (br, 1H, 70H) , 2.39 (s, 3H, 4Ac), 2.30 (m, 2H, H14) , 2.24 (s, 3H, lOAc) , 1.83 (m, 1H, H6G) , 1.82 (br s, 3H, Mel8), 1.68 (s, 1H, 10H), 1.68 (s, 3H, Mel9), 1.24 (s, 3H, Mel7), 1.14 (s, 3H, Mel6). <br><br> 24 4 4 5E <br><br> 24 <br><br> wherein Np^ is no <br><br> Preparation of 3'-desphenyl-3'-(1-naphthyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -4 5 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(l-naphthyl)azetidin-2-one (620 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 325 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-3'-desphenyl-3'-(1-naphthyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 325 mg (0.287 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give yjVr £'V &gt; <br><br> V C <br><br> . 1 <br><br> T-** i i ^ ^A';on J <br><br> 24 4 4 58 <br><br> 25 <br><br> 166 mg (64%) of 3'-(1-naphthyl) taxol, which was recrystallized from methanol/water. <br><br> m.p. 164-165 °C;[a]25Na-52.6° (c 0.005, CHC13). <br><br> 1H NMR (CDCI3, 300 MHz) 5 8.11 (d, J = 7.1 Hz, 2H, benzoate ortho), 8.11 (m, 3H, aromatic), 7.91 (m, 3H, aromatic), 7.70 (m, 2H, aromatic), 7.63-7.46 (m, 7H, aromatic), 6.75 (d, J = 8.8 Hz, 1H, NH), 6.52 (dd, J = 8.8, 1.6 Hz, 1H, H3 ' ) , 6.27 (s, 1H, H10) , 6.27 (dd, J = 9.1, 9.1 Hz, 1H, H13) , 5.68 (d, J = 7.1 Hz, 1H, H2fi) , 4.85 (dd, J = 7.6, 2.2 Hz, 1H, H5) , .4.97 (dd, J = 1.6 Hz, 1H, H2'), 4.39 (m, 1H, H7) , 4.24 (d, J = 8.5 Hz, 1H, H20a) , 4.17 (d, J = 8.5 Hz, 1H, H20f3) , 3.80 (d, J = 7.1 Hz, 1H, H3) , 3.65 (br, 1H, 2'OH), 2.55 (m, 1H, H6a), 2.48 (br, 1H, 70H), 2.41 (s, 3H, 4 Ac) , 2.38 (m, 1H, H14) , 1.96 (s, 3H, lOAc), 1.86 (m, 1H, H6I3), 1.80 (br s, 3H, Mel8), 1.76 (s, 1H, 10H), 1.69 (s, 3H, Mel9), 1.28 (s, 3H, Mel7), 1.16 (s, 3H, Mel6). <br><br> v <br><br> O <br><br> 24445ft <br><br> 26 <br><br> EXAMPLE 6 <br><br> MbO <br><br> OH <br><br> Preparation of 3'-desphenyl-3'-(4-methoxyphenyl) <br><br> taxol, <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(4-methoxyphenyl)azetidin-2-one (590 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-27-(bis)triethylsilyl-3'-desphenyl-3'-(4-methoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 320 mg (0.288 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred ^^for <br><br> \ r O \ <br><br> •C' \\ <br><br> ' J/} kt. Of <br><br> '\ <br><br> •N <br><br> ' V * <br><br> o <br><br> 24 4 <br><br> 27 <br><br> 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 172 mg (68%) of 3'-desphenyl-3'-(4-methoxyphenyl) taxol, which was recrystallized from methanol/water. <br><br> m.p. 174-176 °C;[a]25Na-48.86° (c 0.05, CHC13). <br><br> 1H NMR (CDCI3, 300 MHz) S 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho) , 7.72 (m, 2H, aromatic), 7.59 (m, 1H, aromatic), 7.53-7.36 (m, 8H, aromatic), 6.96 (d, J ~ 8.8 Hz, 1H, NH), 6.90 (m, 2H, aromatic), 6.26 (s, 1H, H10) , 6.21 (dd, J = 9.3, 9.3 Hz, 1H, H13) , 5.70 (dd, J = 8.8, 2.7 Hz, 1H, H3 •) , 5.66 (d, J = 6.8 Hz, 1H, H2I3) , 4.93 (dd, J = 9.9, 2.2 Hz, 1H, H5) , 4.74 (dd, J = 5.5, 2.7 Hz, 1H, H2' ) , 4.39 (m, 1H, H7) , 4.29 (d, J = 8.8 Hz, 1H, H20a) , 4.18 (d, J = 8.8 Hz, 1H, H20G), 3.78 (d, J = 6.8 Hz, 1H, H3), 3.78 (s, 3H, ArOMe) . 3.67 (d, J = 5.5 Hz, 1H, 2'OH), 2.61 (m, 1H, H6a) , 2.50 (d, J = 4.4 Hz, 1H, 70H) , 2.37 (s, 3H, 4Ac), 2.31 (m, 2H, H14) , 2.22 (s, 3H, lOAc) , 1.84 (m, 1H, H6B) , 1.79 (br s, 3H, Mel8), 1.79 (s, 1H, IOH) , 1.67 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.13 (s, 3H, Mel6). <br><br> ■v <br><br> 24 4458 <br><br> 28 <br><br> EXAMPLE 7 <br><br> CI <br><br> OH <br><br> Preparation of 3'-desphenyl-3'-(4-chlorophenyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 inL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(4-chlorophenyl)azetidin-2-one (595 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2*,7-(bis)triethylsilyl 3'-desphenyl-3'-(4-chlorophenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 320 mg (0.287 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred&gt;\a£.:4K °C for <br><br> : * <br><br> \\ 1a ■ '■ <br><br> Of! <br><br> ^ "&gt;1992 *j} <br><br> 24 44 58 <br><br> 29 <br><br> 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 158 mg (62%) of 3'-desphenyl-3'-(4-chlorophenyl) taxol, which was recrystallized from methanol/water. <br><br> m <br><br> .p. 173-175 °C;[a]25Na-50.8° (c 0.01, CHCI3) <br><br> 1H NMR (CDCI3, 300 MHz) S 8.13 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.72 (d, J = 8.2 Hz, 2H, benzamide ortho), 7.65-7.35 (m, 10H, aromatic), 6.97 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10) , 6.25 (dd, J = 8.3, 8.3 Hz, 1H, H13), 5.78 (dd, J = 8.8, 2.2 Hz, 1H, H3') , 5.67 (d, J = 7.1 Hz, 1H, H2I3) , 4.95 (dd, J = 8.8, 2.2 Hz, 1H, H5) , 4.77 (br s, 1H, H2'), 4.40 (m, 1H, H7), 4.31 (d, J = 8.2 Hz, 1H, H20a), 4.19 (d, J = 8.2 Hz, 1H, H20I3) , 3.80 (d, J = 7.1 Hz, 1H, H3), 3.61 (br s, 1H, 2*OH), 2.54 (m, 1H, H6a), 2.38 (s, 3H, 4Ac), 2.32 (m, 2H, H14), 2.24 (s, 3H, lOAc), 1.85 (m, 1H, H6fi), 1.80 (br s, 3H, Mel8) , 1.68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6). <br><br> 24 4458 <br><br> Preparation of 3'-desphenyl-3'-(4-bromophenyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution in nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(4-bromophenyl) azetidin-2-one (660 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2' ,7-(bis)triethylsilyl-3'-desphenyl-3'-(4-bromophenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 330 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixture was stirred afcr-JO. °C for 3 h, then at 25 °C for 13 h, and partitioned ^e"t'ft&amp;en <br><br> 24 44 58 <br><br> 31 <br><br> saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 265 mg of material which was purified by flash chromatography to give 186 mg (64%) of 3'-desphenyl-3'-(4-bromophenyl) taxol, which was recrystallized from methanol/water. <br><br> m.p. 170-172 °C;[a]25Na-50.94° (c 0.01, CHCI3). <br><br> ■^H NMR (CDCI3, 300 MHz) S 8.12 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.71 (m, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.50-7.47 (m, 6H, aromatic), 7.38 (m, 3H, aromatic), 7.04 (d, J = 8.8 Hz, 1H, NH), 6.27 (s, 1H, H10), 6.23 (dd, J = 8.2, 8.2 Hz, 1H, H13), 5.75 (dd, J = 8.8, 2.2 Hz, 1H, H31), 5.66 (d, J » 7.1 Hz, 1H, H2fl), 4.94 (dd, J = 9.3, 1.7 Hz, 1H, H5), 4.75 (dd, J = 2.2 Hz, 1H, H2•), 4.38 (m, 1H, H7), <br><br> 4.29 (d, J = 8.2 Hz, 1H, H20a) , 4.18 (d, J = 8.2 Hz, 1H, H20I3), 3.79 (d, J = 7.1 Hz, 1H, H3), 3.7 (br, 1H, 2'OH), 2.53 (m, 1H, H6a), 2.38 (br, 1H, 70H), 2.37 (s, 3H, 4Ac) , <br><br> 2.30 (m, 2H, H14) , 2.23 (s, 3H, 10Ac), 1.87 (m, 1H, H6I3) , 1.80 (br s, 3H, Mel8), 1.80 (s, 1H, IOH), 1.67 (s, 3H, Mel9), 1.22 (s, 3H, Mel7), 1.13 (s, 3H, Mel6). <br><br> £ /V <br><br> •••V c\ <br><br> » «1,\ V <br><br> (I 1 $ J A «, c)l <br><br> \.&lt;i n-JJ <br><br> 'A ' ' <br><br> . '** 1 \&gt; r O, -• <br><br> 2 4 4 4 5 8 <br><br> 32 <br><br> EXAMPLE 9 <br><br> OH <br><br> Preparation of 3'-desphenyl-3'-(3,4-methylene-dioxyphenyl) taxol. <br><br> To a solution of 7-triethyTsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(3,4-methylenedioxyphenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2 ' R, 3'S)-2',7-(bis)triethylsilyl-3 ' -desphenyl-3'-(3,4-methylenedioxyphenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 320 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C wasfa^ed 2.8 <br><br> ,y <br><br> A <br><br> 24 44 58 <br><br> 33 <br><br> mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 113 mg of material which was purified by flash chromatography to give 165 mg (64%) of 3-desphenyl-3'-(3,4-methylenedioxyphenyl) taxol, which was recrystallized from methanol/water. <br><br> m <br><br> .p. 178-180 °C; [&lt;x]25Na-46.6° (c 0.005, CHCI3) <br><br> 1H NMR (CDCI3, 300 MHz) S 8.14 (d, J = 7.2 Hz, 2H, benzoate ortho), 7.72 (m, 2H, aromatic), 7.15 (m, 1H, aromatic), 7.50 (m, 2H, aromatic), 7.38 (m,2H, aromatic), 7.0 (m, 1H, aromatic), 6.94 (m, 2H, aromatic), 6.88 (d, J = 9.1 Hz, 1H, NH), 6.83 (m, 1H, aromatic), 6.28 (s, 1H, H10), 6.23 (dd, J = 9.1, 9.1 Hz, 1H, H13), 5.97 (s, 2H, methylene), 5 . o9 (dd, J = 9.1, 2.5 Hz, 1H, H3' ) , 5.68 (d, J « 6.9 Hz, 1H, H2I3) , 4.95 (dd, J = 9.6, 2.2 Hz, 1H, H5), 4.72 (dd, J = 2.5 Hz, 1H, H2'), 4.41 (m, 1H, H7), 4.31 (d, J = 8.4 Hz, 1H, H20a), 4.20 (d, J = 8.4 Hz, 1H, H20B), 3.81 (d, J = 6.9 Hz, 1H, H3), 3.60 (br, 1H, 2'OH), 2.56 (m, 1H, H6a), 2.43 (d, J = 4.1 Hz, 1H, 70H) , 2.39 (s, 3H, 4Ac) , 2.31 (m, 2H, H14), 2.24 (s, 3H, lOAc), 1.88 (m, 1H, H6IB) , 1.82 (br s, 3H, Mel8), 1.69 (S, 1H, 10H) , 1.68 (s, 3H, Mel9), 1.24 (s, 3H, Mel7), 1.15 (s, 3H, Mel6). <br><br> .•/" ^ o <br><br> &lt;&lt;•&gt; \, <br><br> .**3 _ — ' <br><br> 1 ; r » <br><br> 24 44 58 <br><br> 34 <br><br> OH <br><br> Preparation of 3'-desphenyl-3'-(3,4-dimethoxy-phenyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(3,4-dimethoxyphenyl)azetidin-2-one (630 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 hr before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 330 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-3 desphenyl-3'-(3,4-dimethoxyphenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 330 mg (0.286 mmol) of the mixture obtained from the previous reaction in. .18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C. gist's a&amp;ded 2.8 <br><br> '' <br><br> .■'•V <br><br> ' &gt; <br><br> : £ fv c <br><br> 24 4458 <br><br> 35 <br><br> mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 260 mg of material which was purified by flash chromatography to give 175 mg (67%) of 3 *-desphenyl-3'-(3,4-dimethoxyphenyl) taxol, which was recrystallized from methanol/water. <br><br> m <br><br> .p. 165-167 °C; [cxJ25Na-42.0o (c 0.005, CHC13) . <br><br> XH NMR (CDC13, 300 MHz) S 8.12 (d, J = 8.3 Hz, 2H, benzoate ortho), 7.73 (d, J = 8.2 Hz, 2H, benzamide ortho), 7.65-7.35 (m, 6H, aromatic), 7.1-7.0 (m, 2H, aromatic), 6.94 (d, J = 8.8 Hz, 1H, NH) , 6.88 (d, J = 8.3 Hz, 2H, aromatic), 6.27 (s, 1H, H10), 6.21 (dd, J = 9.3, 9.3 Hz, lh, H13) , 5.69 (m, 2H, H3, H2IB) , 4.94 (dd, Hz, J = 9.9, 2.2 Hz, 1H, H5), 4.77 (d, J = 2.8 Hz, 1H, H21 ) , 4.39 (dd, J = 11.0, 6.6 Hz, 1H, H7), 4.30 (d, J = 8.5 Hz, 1H, H20a), 4.19 (d, J = 8.5 Hz, 1H, H20I3), 3.88 (s, 3H, ArOtle) , 3.87 (s, 3H, ArOMe), 3.80 (d, J = 7.1 Hz, 1H, H3), 3.59 (d, J = 4.4 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.38 (s, 3H, 4Ac), 2.36 (m, 2H, H14a, H14I3) , 2.23 (s, 3H, lOAc) , 1.86 (m, 1H, H6B) , 1.80 (br s, 3H, Mel8), 1.68 (s, 3H, Mel9) , 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6). <br><br> 24 4 4 5 0i <br><br> 36 <br><br> EXAMPLE 11 <br><br> O Ph O <br><br> OAc <br><br> AAA /= <br><br> EtO N oiiii'"' <br><br> H OH <br><br> OH <br><br> Preparation of N-debenzoyl-N-ethoxycarbonyl taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (155 mg, 0.221 mmol) in 2 mL of THF at -45 °C was added dropwise 0.136 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-ethoxycarbonyl-3-triethylsilyloxy-4-phenylazetidin-2-one (386 mg, 1.11 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 252 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-ethoxycarbonyl taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 252 mg (0.112 mmol) of the mixture obtained from the previous reaction in 12 mL of acetonitrile and 0.6 mL of pyridine at 0 °C was added 1.8 mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between <br><br> 7 ' <br><br> &gt;\ 18 J'^l993 £/ <br><br> A • J <br><br> s,-.p;v£. <br><br> 24 4 4 58 <br><br> 37 <br><br> saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 216 mg of material which was purified by flash chromatography to give 155 mg (85%) of N-debenzoyl-N-ethoxycarbonyl taxol, which was recrystallized from methanol/water. <br><br> m.p. 161.5-162.5 °C; [a]25Na-62 .2° (c 0.51, CHCI3) . <br><br> ifi NMR (CDC13, 300 MHz) S 8.12 (d, J = 7.7 Hz, 2H, benzoate ortho), 7.65-7.3 (m, 8H, aromatic), 6.28 (m, 1H, H10) 6.27(m, 1H, H13) , 5.67 (d, J = 7.1 Hz, 1H, H2I3), 5.53 (d, J = 9.3 Hz, 1H, H3'), 5.29 (d, J = 9.3 Hz, 1H, NH), 4.94 (dd, J = 9.3, 2.2 Hz, 1H, H5) , 4.64 (dd, J = 5.0, 2.8 Hz, 1H, H2' ) , 4.41 (m, 1H, H7), 4.29 (d, J = 8.5 Hz, 1H, H20a), 4.17 (d, J = 8.5 Hz, 1H, H20B) , 4.01 (q, J = 7.1 Hz, 2H, COO£H2CH3), 3.79 (d, J = 7.1 Hz, 1H, H3), 3.45 (d, J = 5 Hz, 1H, 2'OH) , 2.54 (m, 1H, H6a) , 2.47 (d, J = 3.9 Hz 1H, 70H) , 2.36 (s, 3H, 4Ac),2.24 (s, 3H, lOAc) , 2.22 (m, 2H, H14a, H14B), 1.87 (m, 1H, H6a), 1.83 (br s, 3H, Mel8), 1.77 (s, 1H, 10H), 1.68 (s, 3H, Mel9), 1.27 (s, 3H, Mel7) , 1.15 (s, 3H, Mel6), 1.14 (t, J = 7.1 Hz, 2H, COOCH2£H3) . <br><br> . ' x O -\ <br><br> i;M <br><br> t *V&gt; \\ <br><br> 24 4 4 <br><br> 38 <br><br> EXAMPLE 12 <br><br> Preparation of 3'-desphenyl-3*-(4-nitrophenyl) <br><br> taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(4-nitrophenyl)azetidin-2-one (610 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 320 mg of a mixture containing (2'R,3'S)-2 ' ,7-(bis)triethylsilyl-3'-desphenyl-3'-(4-nitrophenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 320 mg (0.284 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C was added 2.8 mL of 48% aqueous HF. The mixtur^was" 's£rirred at 0 °C for <br><br> Ojj f 8 J A N tianv uyj o <br><br> : • r t M o sy*' <br><br> a // <br><br> 14 4458 <br><br> 39 <br><br> 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 255 mg of material which was purified by flash chromatography to give 147 mg (57%) of 3'-desphenyl-3'-(4-nitrophenyl) taxol, which was recrystallized from methanol/water. <br><br> m.p. 188-190 °C; [&lt;x]25Na-63.7° (c 0.01, CHC13) . <br><br> 1H NMR (CDC13, 300 MHz) 5 8.26 (d, J = 8.8 Hz, 2H, benzoate ortho), 8.20 (m, 2H, aromatic), 7.73 (m, 4H, aromatic), 7.60 (m, 1H, aromatic), 7.52 (m, 4H, aromatic), 7.41 (m, 1H, aromatic), 7.15 (d, J = 8.8 Hz, 1H, NH), 6.26 (s, 1H, H10) , 6.26 (dd, J = 9.3, 9.3 Hz, 1H, H13), 5.93 (dd, J = 8.8, 2.8 Hz, 1H, H3') , 5.66 (d, J = 6.6 Hz, 1H, H2I3), 4.94 (dd, J = 9.3, 1.7 Hz, 1H, H5), 4.82 (dd, J = 3.9, 2.8 Hz, 1H, H2'), 4.38 (m, 1H, H7), 4.30 (d, J = 8.8 Hz, 1H, H20a), 4.19 (d, J = 8.8 Hz, 1H, H20I3) , 3.86 (d, J = 3.9 Hz, 1H, 2 ' OH) , 3.79 (d, J = 6.6 Hz, 1H, H3), 2.55 (m, 1H, H6a), 2.46 (d, J = 3.8 Hz, 1H, 70H), 2.41 (s, 3H, 4Ac) , 2.38 (m, 2H, H14) , 2.23 (s, 3H, lOAc) , 1.82 (m, 1H, H6B) , 1.80 (br s, 3H, Mel8), 1.74 (s, 1H, 10H) , 1.68 (s, 3H, Mel9), 1.21 (s, 3H, Me17), 1.13 (s, 3H, Mel6). <br><br> 40 <br><br> EXAMPLE 13 <br><br> 24 44 58 <br><br> o o <br><br> OAc <br><br> XXX x <br><br> N =■ O'iniik <br><br> Ph N <br><br> H OH <br><br> C4) <br><br> Preparation of N-debenzoyl-N-methoxycarbonyl taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (100 mg, 0.143 mmol) in 1 mL of THF at - 45°C was added dropwise 0.087 mL of a 163M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-methoxycarbonyl-3-triethylsilyloxy-4-phenylazetidin-2-one (252 mg, 0.715 mmol) in 1 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between • saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 129 mg of a mixture containing (2 *R,3'S)-2',7-(bis)triethylsilyl-N-debenzoyl-N-methoxycarbonyl taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 129 mg (0.112 mmol) of the mixture obtained from the previous reaction in 6 mL of acetonitrile and 0.3 mL of pyridine at 0 rXd--was added 0.9 <br><br> \ 8 jA^i99^ £f <br><br> // <br><br> 4 4 4 5 8; <br><br> 41 <br><br> mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 108 mg of material which was purified by flash chromatography to give 90 mg (76%) of N-debenzoyl-N-methoxycarbonyl taxol, which was recrystallized from methanol/water. <br><br> m <br><br> .p. 169-171 °C; [a]25Na-63.7° (c 1.1, CHC13). <br><br> 1H NMR (CDC13, 300 MHz) S 8.12 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.65-7.3 (m, 8H, aromatic), 6.28 (m, 2H, H10, H13), 5.66 (d, J = 7.1 Hz, 1H, H213) , 5.58 (d, J = 9.4 Hz, 1H, H3'), 5.30 (d, J = 9.4 Hz, 1H, NH), 4.93 (dd, J = 9.3, 1.7 Hz, 1H, H5), 4.65 (br s, 1H, H2'), 4.40 (m, 1H, H7), 4.29 (d, J = 8.8 Hz, 1H, H20a) , 4.17 (d, J = 8.8 Hz, 1H, H20I3) , 3.79 (d, J = 7.1 Hz, 1H, H3), 3.58 (s, 3H, COOMfi), 3.34 (d, J = 5 Hz, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.47 (d, J = 3.8 Hz 1H, 7 OH) , 2.36 (s, 3H, 4Ac),2.24 (s, 3H, lOAc) , 2.22 (m, 2H, H14a, H1413) , 1.88 (m, 1H, H6a) , 1.82 (br s, 3H, Mel8) , 1.73 (s, 1H, IOH), 1.68 (s, 3H, Mel9), 1.27 (s, 3H, Mel7), 1.14 (s, 3H, Mel6). <br><br> % o , <br><br> t, f +C <br><br> •\ 18 y <br><br> , f? r + f <br><br> 24 4 4 58 <br><br> 42 <br><br> EXAMPLE 14 <br><br> Preparation of 3'-desphenyl-3(4-fluorophenyl) <br><br> taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (200 mg, 0.286 mmol) in 2 mL of THF at -45 °C was added dropwise 0.174 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-benzoyl-3-tri-ethylsilyloxy-4-(4-fluorophenyl)azetidin-2-one (570 mg, 1.43 mmol) in 2 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHC03 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 315 mg of a mixture containing (2*R,3'S)-2',7-(bis)triethylsilyl-3'-desphenyl-3'-(4-fluorophenyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 315 mg (0.286 mmol) of the mixture obtained from the previous reaction in 18 mL of acetonitrile and 0.93 mL of pyridine at 0 °C.was added 2.8 <br><br> O v <br><br> / <br><br> J . g <br><br> A T'/J <br><br> // <br><br> •tj „ O /&gt;v <br><br> ' •r * v <br><br> 4 4458 <br><br> 43 <br><br> mL of 48% aqueous HF. The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 250 mg of material which was purified by flash chromatography to give 160 mg (64%) of 3'-desphenyl-3'-(4-fluorophenyl) taxol, which was recrystallized from methanol/water. <br><br> m.p.171-173 °C;[a]25Na-49.0° (c 0.005, CHCI3). <br><br> 1H NMR (CDCI3, 300 MHz) 6 8.13 (d, J = 7.5 Hz, 2H, benzoate ortho), 7.25 (m, 2H, aromatic), 7.61 (m, 1H, aromatic), 7.50 (m, 4H, aromatic), 7.43 (m, 2H, aromatic), 7.10 (m, 2H, aromatic), 6.96 (d, J = 8.7 Hz, 1H, NH), 6.27 (s, 1H, H10) , 6.25 (dd, J = 8.7, 8.7 Hz, 1H, H13), 5.79 (dd, J = 8.7, 2.4 Hz, 1H, H3 ' ) , 5.67 (d, J = 7.1 Hz, 1H, H2I3) , 4.45 (dd, J = 7.9 Hz, 1H, H5), 4.76 (dd, J = 4.8, 2.4 Hz, 1H, H21 ) , 4.39 (m, 1H, H7) , 4.31 (d, J = 8.9 Hz, 1H, H20a) , 4.20 (d, J = 8.9 Hz, 1H, H20I3), 3.80 (d, J = 7.1 Hz, 1H, H3), 3.57 (d, J = 4.8 Hz, 1H, 2'OH), 2.58 (m, 1H, H6a) , 2.43 (d, J = 4.3 Hz, 1H, 70H), 2.38 (s, 3H, 4Ac), 2.30 (m, 2H, H14), 2.24 (s, 3H, lOAc), 1.85 (m, 1H, H6I3), 1.80 (br s, 3H, Mel8), 1.69 (s, 1H, 10H) , 1.55 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6). <br><br> *0 \ f <br><br> \V <br><br> 1 o ' <br><br> •\ ?•/ <br><br> 44 <br><br> EXAMPLE 15 <br><br> 4 4 4 58' <br><br> o ^ o <br><br> OAC <br><br> I § H OH <br><br> C5) <br><br> Preparation of 3'-Desphenyl-3(2-thienyl) taxol. <br><br> To a solution of 7-triethylsilyl baccatin III (100 mg, 0.143 mmol) in 1 mL of THF at -45 °C was added dropwise 0.087 mL of a 1.63M solution of nBuLi in hexane. After 0.5 h at -45 °C, a solution of cis-l-(4-benzoyl)-3-triethylsilyloxy-4-(2-thienyl)azetidin-2-one (277 mg, 0.715 mmol) in 1 mL of THF was added dropwise to the mixture. The solution was warmed to 0 °C and kept at that temperature for 1 h before 1 mL of a 10% solution of AcOH in THF was added. The mixture was partitioned between saturated aqueous NaHCC&gt;3 and 60/40 ethyl acetate/hexane. Evaporation of the organic layer gave a residue which was purified by filtration through silica gel to give 169 mg of a mixture containing (2'R,3'S)-2',7-(bis)triethylsilyl-3'-desphenyl-3'-(2-thienyl) taxol and a small amount of the (2'S,3'R) isomer. <br><br> To a solution of 169 mg of the mixture obtained from the previous reaction in 6 mL of acetonitrile and 0.3 mL of pyridine at 0 °C was added 0.9 mL of 48% aqueous HF. <br><br> I <br><br> • 13 jAKI99$ <br><br> ^ - // <br><br></p> </div>

Claims (6)

<div class="application article clearfix printTableText" id="claims"> <p lang="en"> 24 4 4 58:<br><br> 45<br><br> The mixture was stirred at 0 °C for 3 h, then at 25 °C for 13 h, and partitioned between saturated aqueous sodium bicarbonate and ethyl acetate. Evaporation of the ethyl acetate solution gave 140 mg of material which was purified by flash chromatography to give 93 mg (76%) of 3'-desphenyl-3'-(2-thienyl) taxol, which was recrystallized from methanol/water.<br><br> m<br><br> .p. 173-175 °C; [&lt;x]25Na-42 .1° (c 0.515, CHCI3) .<br><br> 1H NMR (CDC13, 300 MHz) S 8.14 (d, J = 7.1 Hz, 2H, benzoate ortho), 7.72 (d, J = 8.7 Hz, 2H, benzamide ortho), 7.65-7.35 (m, 6H, aromatic), 7.31 (dd, J = 5.5, 1.1 Hz, 1H, thienyl), 7.19 (dd, J =3.9, 1.1 Hz, 1H, thienyl), 7.03 (dd, J = 5.5, 3.9 Hz, 1H, thienyl), 6.96 (d, J = 8.8 Hz, 1H, NH), 6.28 (s, 1H, H10) , 6.24 (dd, J = 8.8, 7.7 Hz, 1H, H13), 6.05 (dd, J = 8.8, 1.7 Hz, 1H, H3'), 5.68 (d, J = 7.1 Hz, 1H, H2), 4.95 (dd, J = 9.3, 1.7 Hz, 1H, H5), 4.78 (d, J = 2.2 Hz, 1H, H2' ) , 4.40 (dd, J = 11.0, 6.6 Hz, 1H, H7) , 4.31 (d, J = 8.5 Hz, 1H, H20a) , 4.20 (d, J = 8.5 Hz, 1H, H20I3), 3.81 (d, J = 7.1 Hz, 1H, H3), 3.72 (br. s, 1H, 2'OH), 2.54 (m, 1H, H6a), 2.41 (s, 3H, 4Ac), 2.37 (m, 2H, H14a, H14B) , 2.23 (s, 3H, lOAc) , 1.88 (m, 1H, H6a) , 1.82 (br s, 3H, Mel8), 1.68 (s, 3H, Mel9), 1.23 (s, 3H, Mel7), 1.14 (s, 3H, Mel6).<br><br> In view of the above, it will be seen that the several objects of the invention are achieved.<br><br> As various changes could be made in the above compositions and processes without departing from the scope of the invention, it is intended that all matter contained in the above description be interpreted as illustrative and not in a limiting sense. „ ^ /<br><br> OI}<br><br> 244458<br><br> 46<br><br> WHAT ^/WE CLAIM IS a<br><br>
1. A metal alkoxide having the following formula:<br><br> z wherein is hydrogen or a hydroxy protecting group, Z is -0T2, or -OCOCH3, T2 is hydrogen or a hydroxy protecting group, M is a metal, Ac is acetyl and Ph is phenyl.<br><br>
2. The metal alkoxide of claim 1 wherein M is Li, Mg, Na, K or Ti.<br><br>
3. The metal alkoxide of claim 1 wherein M is lithium.<br><br>
4. The metal alkoxide of claim 1 wherein M is lithium, Z is -OT2, and T2 is a hydroxy protecting group.<br><br>
5. The metal alkoxide of claim 4 wherein Tj and T2 are independently selected from the group consisting of 1-ethoxyethyl, 2,2,2-trichloroethoxymethyl, trialkyl silyl and triaryl silyl.<br><br>
6. A metal alkoxide according to any one of claims 1 to 5<br><br> </p> </div>
NZ244458A 1991-09-23 1992-09-23 Metal alkoxides of taxane derivatives NZ244458A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76380591A 1991-09-23 1991-09-23
US07/862,778 US5229526A (en) 1991-09-23 1992-04-03 Metal alkoxides

Publications (1)

Publication Number Publication Date
NZ244458A true NZ244458A (en) 1994-06-27

Family

ID=27117339

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ244458A NZ244458A (en) 1991-09-23 1992-09-23 Metal alkoxides of taxane derivatives

Country Status (24)

Country Link
US (1) US5229526A (en)
EP (1) EP0605638B1 (en)
JP (1) JP3320416B2 (en)
CN (1) CN1058714C (en)
AT (1) ATE184004T1 (en)
AU (1) AU643911B2 (en)
CA (1) CA2098568C (en)
CZ (1) CZ289299B6 (en)
DE (1) DE69229916T2 (en)
DK (1) DK0605638T3 (en)
ES (1) ES2137951T3 (en)
FI (1) FI109796B (en)
HU (1) HU225914B1 (en)
IL (1) IL103192A (en)
MX (1) MX9205370A (en)
MY (1) MY128481A (en)
NO (1) NO305120B1 (en)
NZ (1) NZ244458A (en)
PH (1) PH30213A (en)
PT (1) PT100884B (en)
RU (1) RU2098413C1 (en)
TW (1) TW368502B (en)
UA (1) UA41287C2 (en)
WO (1) WO1993006094A1 (en)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5430160A (en) * 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US6028205A (en) * 1991-09-23 2000-02-22 Florida State University C2 tricyclic taxanes
US6005138A (en) 1991-09-23 1999-12-21 Florida State University Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US5728725A (en) * 1991-09-23 1998-03-17 Florida State University C2 taxane derivaties and pharmaceutical compositions containing them
US6495704B1 (en) 1991-09-23 2002-12-17 Florida State University 9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
US5714513A (en) * 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US6018073A (en) * 1991-09-23 2000-01-25 Florida State University Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6335362B1 (en) 1991-09-23 2002-01-01 Florida State University Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US6521660B2 (en) 1991-09-23 2003-02-18 Florida State University 3′-alkyl substituted taxanes and pharmaceutical compositions containing them
US5728850A (en) * 1991-09-23 1998-03-17 Florida State University Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
ZA926827B (en) * 1991-09-23 1993-03-15 Univ Florida State Novel furyl and thienyl substituted taxanes and pharmaceutical compositions containing them.
US5998656A (en) * 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
US7074945B2 (en) * 1991-09-23 2006-07-11 Florida State University Metal alkoxide taxane derivatives
US6011056A (en) * 1991-09-23 2000-01-04 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
US5739362A (en) * 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.
FR2698363B1 (en) * 1992-11-23 1994-12-30 Rhone Poulenc Rorer Sa New taxane derivatives, their preparation and the compositions containing them.
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
FR2698871B1 (en) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
DK0679156T3 (en) * 1993-01-15 2000-09-04 Univ Florida State Process for the preparation of 10-desacetoxybaccatin III and 10-desacetoxytaxol and derivatives thereof
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
US6187916B1 (en) * 1993-02-01 2001-02-13 Research Foundation Of State University Of New York Process for the preparation of taxane derivatives and β-lactam intermediates therefor
US6593482B2 (en) 1993-02-01 2003-07-15 Aventis Pharma S.A. Methods for preparing new taxoids and pharmaceutical compositions containing them
US6710191B2 (en) 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
US6066747A (en) * 1993-03-05 2000-05-23 Florida State University Process for the preparation of 9-desoxotaxanes
US5547981A (en) * 1993-03-09 1996-08-20 Enzon, Inc. Taxol-7-carbazates
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
WO1994021252A1 (en) * 1993-03-22 1994-09-29 Florida State University Taxanes having a pyridyl substituted side-chain
EP1260223B1 (en) * 1993-03-22 2005-05-11 Florida State University Taxanes having furyl or thienyl substituted side-chain
FR2703049B1 (en) 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Method for the purification of taxoids.
IT1261667B (en) * 1993-05-20 1996-05-29 TAX FOR ANTI-CANCER ACTIVITIES.
AU693797B2 (en) * 1993-07-19 1998-07-09 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
US5405972A (en) * 1993-07-20 1995-04-11 Florida State University Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
US6005120A (en) 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US5880131A (en) * 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
JPH09504033A (en) * 1993-10-20 1997-04-22 エンゾン,インコーポレーテッド 2'- and / or 7-substituted taxoids
US6441026B1 (en) 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
FR2718137B1 (en) * 1994-04-05 1996-04-26 Rhone Poulenc Rorer Sa Process for the preparation of trialcoylsilyl-7 baccatine III.
FR2722191B1 (en) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa PROCESS FOR THE PREPARATION OF (2R, 3S) -3-TERTBUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE (2R, 3S) TRIHYDRATE, 20EPOXY-11BYA -13ALPHA-YLE
US6201140B1 (en) 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (en) 1995-03-27 1996-10-01 Aventis Pharma Sa NEW TAXOIDS, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
US5760251A (en) * 1995-08-11 1998-06-02 Sepracor, Inc. Taxol process and compounds
JP2001524067A (en) * 1995-09-13 2001-11-27 フロリダ・ステイト・ユニバーシティ Radiation sensitizing taxanes and their pharmaceutical preparations
US6177456B1 (en) 1995-10-02 2001-01-23 Xechem International, Inc. Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
US5854278A (en) * 1995-12-13 1998-12-29 Xechem International, Inc. Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
US5807888A (en) * 1995-12-13 1998-09-15 Xechem International, Inc. Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
US5654448A (en) * 1995-10-02 1997-08-05 Xechem International, Inc. Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
US5840748A (en) * 1995-10-02 1998-11-24 Xechem International, Inc. Dihalocephalomannine and methods of use therefor
CA2253513A1 (en) * 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5750736A (en) * 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5750737A (en) * 1996-09-25 1998-05-12 Sisti; Nicholas J. Method for paclitaxel synthesis
US5973170A (en) * 1996-09-25 1999-10-26 Napro Biotherapuetics, Inc. C-7 metal alkoxides of baccatin III
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US6017935A (en) * 1997-04-24 2000-01-25 Bristol-Myers Squibb Company 7-sulfur substituted paclitaxels
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US5914411A (en) * 1998-01-21 1999-06-22 Napro Biotherapeutics, Inc. Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
US6066749A (en) * 1998-05-01 2000-05-23 Napro Biotherapeutics, Inc. Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis
ES2230849T3 (en) 1998-05-01 2005-05-01 Tapestry Pharmaceuticals, Inc. USEFUL PROCEDURES AND INTERMEDIARIES FOR THE SYNTHESIS OF PACLITAXEL FROM C-7, C-10 DI-CBZ BACATINA III.
US6025516A (en) * 1998-10-14 2000-02-15 Chiragene, Inc. Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
US6136999A (en) * 1999-06-21 2000-10-24 Napro Biotherapeutics, Inc. C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof
US6143902A (en) * 1999-06-21 2000-11-07 Napro Biotherapeutics, Inc. C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6548293B1 (en) 1999-10-18 2003-04-15 Fsu Research Foundation, Inc. Enzymatic process for the resolution of enantiomeric mixtures of β-lactams
US7063977B2 (en) * 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
WO2003047508A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Paclitaxel solvates
US6703599B1 (en) * 2002-01-30 2004-03-09 Microsoft Corporation Proximity sensor with adaptive threshold
US20040132991A1 (en) * 2002-10-09 2004-07-08 Phytogen Life Sciences Inc. Novel taxanes and methods related to use and preparation thereof
US7030253B2 (en) * 2003-08-07 2006-04-18 Bristol-Myers Squibb Company Process for preparing 4-alkyl- or 4-aryl-oxycarbonyl paclitaxel analogs and novel intermediates
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
US20050272807A1 (en) * 2004-06-04 2005-12-08 Phytogen Life Sciences Inc. Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
US20050288520A1 (en) * 2004-06-25 2005-12-29 Phytogen Life Sciences Inc. One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
JP2006302679A (en) * 2005-04-21 2006-11-02 Seiko Epson Corp Formation method of conductive film and manufacturing method of electronic apparatus
WO2006116532A2 (en) * 2005-04-28 2006-11-02 University Of Massachusetts Lowell Synthesis of oligo/poly(catechins) and methods of use
WO2008051465A2 (en) * 2006-10-20 2008-05-02 Scinopharm Singapore Pte, Ltd. Process for making crystalline anhydrous docetaxel
CN101289432B (en) * 2007-04-20 2010-12-15 上海天伟生物制药有限公司 Novel isoserine ester derivates and method for preparing same
WO2009137084A2 (en) * 2008-05-07 2009-11-12 Ivax Research, Llc Processes for preparation of taxanes and intermediates thereof
KR101096282B1 (en) 2009-04-24 2011-12-20 주식회사 삼양제넥스 Method for Preparing Taxane Derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2601676B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF TAXOL AND DESACETYL-10 TAXOL
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
FR2629818B1 (en) * 1988-04-06 1990-11-16 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF TAXOL
FR2629819B1 (en) * 1988-04-06 1990-11-16 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF BACCATIN III AND DESACETYL-10 BACCATIN III DERIVATIVES
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone

Also Published As

Publication number Publication date
HUT66398A (en) 1994-11-28
IL103192A (en) 1997-06-10
FI109796B (en) 2002-10-15
FI941323A0 (en) 1994-03-22
FI941323A (en) 1994-03-22
MX9205370A (en) 1993-03-31
JP3320416B2 (en) 2002-09-03
ATE184004T1 (en) 1999-09-15
MY128481A (en) 2007-02-28
CZ66294A3 (en) 1994-12-15
US5229526A (en) 1993-07-20
CZ289299B6 (en) 2001-12-12
EP0605638B1 (en) 1999-09-01
DE69229916T2 (en) 2000-02-17
HU225914B1 (en) 2007-12-28
PT100884A (en) 1993-11-30
CA2098568C (en) 1997-06-03
DK0605638T3 (en) 2000-02-28
CN1058714C (en) 2000-11-22
PT100884B (en) 1999-07-30
TW368502B (en) 1999-09-01
AU2688892A (en) 1993-04-27
DE69229916D1 (en) 1999-10-07
NO305120B1 (en) 1999-04-06
WO1993006094A1 (en) 1993-04-01
EP0605638A4 (en) 1994-08-24
PH30213A (en) 1997-02-05
AU643911B2 (en) 1993-11-25
HU9400831D0 (en) 1994-06-28
JPH07502982A (en) 1995-03-30
EP0605638A1 (en) 1994-07-13
ES2137951T3 (en) 2000-01-01
NO941020L (en) 1994-05-20
CA2098568A1 (en) 1993-03-24
CN1075718A (en) 1993-09-01
NO941020D0 (en) 1994-03-22
UA41287C2 (en) 2001-09-17
RU2098413C1 (en) 1997-12-10
IL103192A0 (en) 1993-02-21

Similar Documents

Publication Publication Date Title
US5229526A (en) Metal alkoxides
US5274124A (en) Metal alkoxides
US5723634A (en) Metal alkoxide compounds
US5254703A (en) Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
CA2098478C (en) Preparation of substituted isoserine esters using metal alkoxides and .beta.-lactams
IE74154B1 (en) Method for preparation of taxol using an oxazinone
US7074945B2 (en) Metal alkoxide taxane derivatives
AU647971C (en) Preparation of isoserine ester and taxane
PT100883B (en) PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES USING METALIC AND B-LACTAMAN ALCOXIDES

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired